Skip to main content

Biosyent Inc(RX-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Biosyent Inc down on Friday (RX)

Automated Summaries - The Globe and Mail - Fri May 3, 4:02PM CDT

In trading today, Biosyent Inc stock opened at $8.75 and closed at $8.65. prices ranged from $8.65 to $8.80.

The price decreased -0.46% from the previous day's close of $8.69.

Today across North America, the TSX Composite closed 0.57% at 21947.41, the S&P 500 closed 0.91% at 5064.20, the Dow Jones Industrial Average closed 0.85% at 38225.66 and the Nasdaq Composite closed 1.51% at 15840.96.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

A total of 9,142 shares was traded during the last trading day, with total trades of 13, while having an average volume of 5,855 in the last five days.

The TSX-V overall saw 3,333 price advancers against 1,844 declines and 124 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, in the last 52 weeks, Biosyent Inc's shares have advanced 16.11%, while they have dipped -6.18% year-to-date.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $100.85 million on a float of 11,605 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Biosyent Inc's consensus rating is "Moderate Buy" based on 1 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe